ShannonKristenPenlandMD

Oncology • Seneca, PA

Hematologist/Oncologist at Cone Health Cancer Center

Join to view full profile

Dr. Penland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Penland's full profile

Already have an account?

Office
100 Fairfield Dr
Seneca, PA 16346
Phone+1 814-676-7900

Fax+1 814-676-7887

Education & Training

University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2002 - 2005
UPMC Medical Education/MercyResidency, Internal Medicine, 2001 - 2002
UPMC Medical Education (Mercy)Internship, Transitional Year, 2000 - 2001
University of Pittsburgh School of MedicineClass of 2000
University of RochesterMS, Organic Chemistry, 1993 - 1996

Certifications & Licensure

OH State Medical License 2018 - 2026
NC State Medical License 2015 - 2025
PA State Medical License 2001 - 2024
MS State Medical License 2008 - 2019
MT State Medical License 2005 - 2009
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

93 citations
CD200 is induced by ERK and is a potential therapeutic target in melanoma
Kimberly B. Petermann, Gabriela I. Rozenberg, Daniel C. Zedek, Pamela A. Groben, Karen P. McKinnon
The Journal of Clinical Investigation. 2007-12-03
128 citations
RNA expression analysis of formalin-fixed paraffin-embedded tumors.
Shannon K. Penland, Temitope O. Keku, Chad Torrice, Xiaping He, Janakiraman Krishnamurthy
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2007-02-12
69 citations
Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of Melanoma
Janiel M. Shields, Nancy E. Thomas, Melissa A. Cregger, Aaron Berger, Michael C. Leslie
Cancer Research. 2007-02-15

Press Mentions

Women and Cancer: Breast CancerJanuary 27th, 2017
Breast Cancer: Latest Treatment OptionsSeptember 26th, 2016